Behavioral Targeting: RJ vs JP

Just when you thought it was safe to go back in the water...bam! In this case, the water is tracking consumer website visits for...

4th Annual Pharmaceutical Product Complaints

Benchmark Against 12 Industry Approaches for Effective Classification and Handling of Product Complaints

Blockbuster or BallBuster?

Erectile dysfuntion (ED) drugs -- Viagra, Cialis, Levitra -- are in the news again. It seems that ED drug marketers have retooled their...

Sales Force Effectiveness

I attended Pharmaceutical Executive's 1st Annual Marketing and Sales Summit today and sat in on a few interesting presentations related to sales force effectiveness....

Medical Device DTC: What’s Up With That?

Medical Device DTC stats was the topic of an interesting discussion thread last week on the Pharma Marketing Forum -- a good place to...

6th Annual Forum on Continuing Medical Education (CME)

Comply with Guidelines and Standards to Maximize and Improve CME Activities

4th Annual Forum on Anonymous Patient Level Data and Analysis

Over 100 senior level executives from top pharmaceutical companies such as Johnson and Johnson, Merck and Wyeth have attended CBI’s premier annual Anonymous Patient Level Data (APLD) meeting to hear key learnings and best strategies for maximizing longitudinal patient-level data.

Easy Access to Blog Topics

Subscribe by EmailIf you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.Enter your Email AddressIndices...

FDA Paralyzed: Who Will Protect Us?

A few weeks ago, I wrote about how the FDA approved Ketek based on foreign trial data. I raised the suspicion that the FDA...

Welcome Back Vioxx, Welcome Back

An editorial in today's Wall Street Journal calls for the return of Vioxx ("Now Bring Back Vioxx") citing a "meta" analysis (wooooo... meta!) published...